BPG is committed to discovery and dissemination of knowledge
Articles in Press
5/21/2025 1:59:18 PM | Browse: 1 | Download: 0
Category |
Endocrinology & Metabolism |
Manuscript Type |
Editorial |
Article Title |
Factors affecting disease control after pituitary tumor resection in acromegaly: What is the current evidence?
|
Manuscript Source |
Invited Manuscript |
All Author List |
Cornelius J Fernandez, Vijaya Lakshmi, Abul Bashar M Kamrul-Hasan and Joseph M Pappachan |
Funding Agency and Grant Number |
|
Corresponding Author |
Joseph M Pappachan, FRCP, MD, Professor, Senior Researcher, Faculty of Science, Manchester Metropolitan University, Oxford Road, Manchester M15 6BH, United Kingdom. drpappachan@yahoo.co.in |
Key Words |
Acromegaly; Pituitary neuroendocrine tumor; Somatostatin receptor; Somatostatin receptor ligands; Transsphenoidal surgery |
Core Tip |
Transsphenoidal surgery is the most effective treatment for acromegaly. Alone, it could achieve a remission rate of 73%. However, when followed by medical therapy, the remission rates could reach 87%. The biochemical remission rates following surgery and medical therapy are highly variable depending on various clinical, biochemical, radiological, histopathological and genetic parameters. Earlier studies have identified tumor size, tumor invasion, T2-weighted hyperintensity, granulation, and pretreatment growth hormone and/or insulin-like growth factor 1 levels as important prognostic markers. A study published by Alvarez et al noted that preoperative pituitary neuroendocrine tumor volume could predict postoperative remission. |
Citation |
Fernandez CJ, Lakshmi V, Kamrul-Hasan ABM, Pappachan JM. Factors affecting disease control after pituitary tumor resection in acromegaly: What is the current evidence? World J Radiol 2025; In press |
 |
Received |
|
2025-02-26 09:44 |
 |
Peer-Review Started |
|
2025-02-26 09:45 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-04-16 10:46 |
 |
Revised |
|
2025-04-18 09:22 |
 |
Second Decision |
|
2025-05-21 02:51 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-05-21 13:59 |
 |
Articles in Press |
|
2025-05-21 13:59 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
ISSN |
1949-8470 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345